The author emphasizes metabolomics' critical role in advancing our understanding of disease mechanisms and accelerating targeted drug development ... potential to enhance target discovery. With clear ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human data and AI.

a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics, today announced a partnership bringing together two leading AI platforms to rapidly ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

Efficiency and cost-effectiveness are key drivers in these recent developments in AI drug discovery and development, given that R&D for a new drug can take up to 18 years. The overarching desire ...

The global health landscape is constantly challenged by the emergence and re-emergence of viral pathogens. While significant ...

XtalPi says AI is reducing drug discovery times to two years from four XtalPi Holdings, an artificial intelligence (AI) drug ...

Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound GK470 (AVX235), and the discovery of a more potent and selective lead, GK420 (AVX420), with significant ...

"We are looking forward to potentially utilising new tools to increase our effectiveness in small molecule drug discovery and development." In addition to supporting its own efforts, Pfizer plans ...

Faro Health Inc., the leading AI-powered platform for data-driven clinical protocol design, today announced it has partnered with Recursion (NASDAQ: RXRX) to accelerate and optimize clinical protocol ...